Skip to content 
Regentis Biomaterials Ltd is an Israel-based regenerative medicine company. The Company is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its lead product is GellinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage. Its implant combines the precision of photopolymerization with the biocompatibility of PEG and fibrinogen, enabling natural tissue regeneration without the need for cell harvesting or culturing. Regentis Biomaterials Ltd aims to address unmet clinical needs in sports medicine and early-stage osteoarthritis. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| RGNT | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| RGNT | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
REGENTIS BIOMATERIALS LTD/IS (RGNT) share price today is $4
Yes, Indians can buy shares of REGENTIS BIOMATERIALS LTD/IS (RGNT) on Vested. To buy
Yes, you can purchase fractional shares of REGENTIS BIOMATERIALS LTD/IS (RGNT) via the Vested app. You can start investing in REGENTIS BIOMATERIALS LTD/IS (RGNT) with a minimum investment of $1.
You can invest in shares of REGENTIS BIOMATERIALS LTD/IS (RGNT) via Vested in three simple steps:
The 52-week high price of REGENTIS BIOMATERIALS LTD/IS (RGNT) is $. The 52-week low price of REGENTIS BIOMATERIALS LTD/IS (RGNT) is $.
The price-to-earnings (P/E) ratio of REGENTIS BIOMATERIALS LTD/IS (RGNT) is
The price-to-book (P/B) ratio of REGENTIS BIOMATERIALS LTD/IS (RGNT) is 0.00
The dividend yield of REGENTIS BIOMATERIALS LTD/IS (RGNT) is 0.00%
The market capitalization of REGENTIS BIOMATERIALS LTD/IS (RGNT) is $20.35M
The stock symbol (or ticker) of REGENTIS BIOMATERIALS LTD/IS is RGNT
Consider the share price of REGENTIS BIOMATERIALS LTD/IS as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether REGENTIS BIOMATERIALS LTD/IS has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in REGENTIS BIOMATERIALS LTD/IS shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the REGENTIS BIOMATERIALS LTD/IS stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of REGENTIS BIOMATERIALS LTD/IS and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that REGENTIS BIOMATERIALS LTD/IS stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
